Access cutting-edge quadriplegia treatment through this clinical trial at a research site in Pasadena. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Pasadena location
Preparing your pre-screening questions…
Access quadriplegia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related quadriplegia treatment provided free
Check if you qualify for this quadriplegia clinical trial in Pasadena, CA
No-Cost Study Care
Local to Pasadena
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The investigators objective is to run human clinical trials in which brain activity recorded through a "brain-chip" implanted in the human brain can be used to provide novel communication capabilities to severely paralyzed individuals by allowing direct brain-control of a computer interface. A prospective, longitudinal, single-arm early feasibility study will be used to examine the safety and effectiveness of using a neural communication system to control a simple computer interface and a tablet computer. Initial brain control training will occur in simplified computer environments, however, the ultimate objective of the clinical trial is to allow the human patient autonomous control over the Google Android tablet operating system. Tablet computers offer a balance of ease of use and functionality that should facilitate fusion with the BMI. The tablet interface could potentially allow the patient population to make a phone call, manage personal finances, watch movies, paint pictures, play videogames, program applications, and interact with a variety of "smart" devices such as televisions, kitchen appliances, and perhaps in time, devices such as robotic limbs and smart cars. Brain control of tablet computers has the potential to greatly improve the quality of life of severely paralyzed individuals. Five subjects will be enrolled, each implanted with the NCS for a period of at least 53 weeks and up to 313 weeks. The study is expected to take at least one year and up to six years in total.
Sponsor: Richard A. Andersen, PhD
Yes, this clinical trial (NCT01958086) has an active research site in Pasadena, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for quadriplegia treatment options in Pasadena, CA, this clinical trial (NCT01958086) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Pasadena research site is actively enrolling participants for this clinical trial. You'll receive care from experienced quadriplegia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all quadriplegia clinical trials near you to find additional studies recruiting in your area.
See all alzheimers disease clinical trials recruiting in Pasadena — not just this study.
Browse Alzheimers Disease Trials in Pasadena →